首页> 外文期刊>The Nursing Clinics of North America >Dernnatologic Reactions to Targeted Therapy A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care
【24h】

Dernnatologic Reactions to Targeted Therapy A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care

机译:针对靶向治疗的Dernatologic反应关注表皮生长因子受体抑制剂和护理

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer treatments usually have side effects of bone marrow depression, mucositis, hair loss, and gastrointestinal issues. Rarely do we think of skin side effects until patients have been treated successfully with epidermal growth factor receptor inhibitors (EGFRi). Those reactions include papulopustular rash, hair changes, radiation dermatitis enhancement, pruritus, mucositis, xerosis, fissures, and paronychia. This article discusses the common skin reactions seen when using EGFRi and presents an overview of skin as the largest and important organ of the body, including an overview of skin assessment, pathophysiology of the skin reactions, nursing, care involved, and introduction to oncodermatology.
机译:癌症治疗通常具有骨髓抑制,粘膜炎,脱发和胃肠道问题的副作用。 我们很少想到皮肤副作用,直到患者成功治疗表皮生长因子受体抑制剂(EGFRI)。 这些反应包括椎弓根,毛发变化,辐射皮炎增强,瘙痒,粘液炎,血清病,裂隙和Paronychia。 本文讨论了使用EGFRI时所见的常见皮肤反应,并呈现皮肤作为身体最大和重要器官的概述,包括皮肤评估,皮肤反应的病理生理学,护理,护理和癌细胞引入的概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号